| 1 |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342): 2227-2242.
|
| 2 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/OL]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 3 |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
|
| 4 |
Qian Y, Cai C, Sun M, et al. Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: A review[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2707-2723.
|
| 5 |
Tashkin DP, Barjaktarevic I, Gomez-Seco J, et al. Prevalence and management of chronic obstructive pulmonary disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy[J]. J Aerosol Med Pulm Drug Deliv, 2024, 37(4): 189-201.
|
| 6 |
van Geffen WH, Tan DJ, Walters JA, et al. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2023, 12(12): CD011600.
|
| 7 |
Feldman WB, Suissa S, Kesselheim AS, et al. Comparative effectiveness and safety of single inhaler triple therapies for chronic obstructive pulmonary disease: new user cohort study[J]. BMJ, 2024, 387: e080409.
|
| 8 |
Calverley PMA, Walker PP. Contemporary Concise Review 2022: Chronic obstructive pulmonary disease[J]. Respirology, 2023, 28(5): 428-436.
|
| 9 |
Rhee CK. Chronic obstructive pulmonary disease research by using big data[J]. Clin Respir J, 2021, 15(3): 257-263.
|
| 10 |
Kahnert K, Jörres RA, Behr J, et al. The diagnosis and treatment of COPD and its comorbidities[J]. Dtsch Arztebl Int, 2023, 120(25): 434-444.
|
| 11 |
Jeyachandran V, Hurst JR. Advances in chronic obstructive pulmonary disease: management of exacerbations[J]. Br J Hosp Med (Lond), 2022, 83(7): 1-7.
|
| 12 |
Schwalk AJ, Patel NM, Madisi NY. Developing interventions for chronic obstructive pulmonary disease[J]. Semin Respir Crit Care Med, 2024, 45(5): 582-592.
|
| 13 |
Guthrie A. Chronic obstructive pulmonary disease series part 4: Identifying, managing, and preventing Exacerbations[J]. Sr Care Pharm, 2023, 38(9): 361-369.
|
| 14 |
李廉策，柴培培，万泉. 我国慢性阻塞性肺疾病负担趋势及影响因素分析[J]. 中国卫生经济，2025, 44(9): 62-66.
|
| 15 |
Patel N. An update on COPD prevention, diagnosis, and management: The 2024 GOLD Report[J]. Nurse Pract, 2024, 49(6): 29-36.
|
| 16 |
陈平，蔡珊，朱应群，等. 肺泡巨噬细胞在慢性阻塞性肺疾病所道炎症中的作用[J]. 中华内科杂志，2001, 40(4): 232-235.
|
| 17 |
Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease[J]. Ann Intern Med, 2020, 173(3): ITC17-ITC32.
|
| 18 |
Lazarinis N, Fouka E, Linden A, et al. Small airways disease in chronic obstructive pulmonary disease[J]. Expert Rev Respir Med, 2024, 18(7): 539-552.
|
| 19 |
梅永添，向薇，覃仕鹤，等. cTnⅠ和CatS水平评估COPD急性加重期并发心力衰竭的价值[J]. 中国急救复苏与灾害医学杂志，2025, 20(7): 946-949.
|
| 20 |
王东梅，李琳驹，余秋帛，等. 老年稳定期COPD患者血清α1-AT、FABP4水平与炎症因子水平和病情程度的相关性及对短期预后的影响[J]. 检验医学与临床，2025, 22(13): 1768-1774.
|
| 21 |
Wiegman CH, Li F, Ryffel B, et al. Oxidative stress in ozone-induced chronic lung inflammation and emphysema: A facet of chronic obstructive pulmonary disease[J]. Front Immunol, 2020, 11: 1957.
|
| 22 |
Taniguchi A, Tsuge M, Miyahara N, et al. Reactive oxygen species and antioxidative defense in chronic obstructive pulmonary disease[J]. Antioxidants (Basel), 2021, 10(10): 1537.
|
| 23 |
Wei YY, Chen TT, Zhang DW, et al. Microplastics exacerbate ferroptosis via mitochondrial reactive oxygen species-mediated autophagy in chronic obstructive pulmonary disease[J]. Autophagy, 2025, 21(8): 1717-1743.
|
| 24 |
Liu L, Wen T, Xiao Y, et al. Sea buckthorn extract mitigates chronic obstructive pulmonary disease by suppression of ferroptosis via scavenging ROS and blocking p53/MAPK pathways[J]. J Ethnopharmacol, 2025, 336: 118726.
|
| 25 |
Zhao X, Zhang Q, Zheng R. The interplay between oxidative stress and autophagy in chronic obstructive pulmonary disease[J]. Front Physiol, 2022, 13: 1004275.
|
| 26 |
Lu Z, Van Eeckhoutte HP, Liu G, et al. Necroptosis signaling promotes inflammation, airway remodeling, and emphysema in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 204(6): 667-681.
|
| 27 |
Verleden SE, Hendriks JMH, Snoeckx A, et al. Small airway disease in pre-chronic obstructive pulmonary disease with emphysema: A cross-sectional study[J]. Am J Respir Crit Care Med, 2024, 209(6): 683-692.
|
| 28 |
Pan M, Zhou X. Airway remodeling in chronic obstructive pulmonary disease: characteristics and opportunities[J]. Front Med (Lausanne), 2025, 12: 1556868.
|
| 29 |
Mikami Y, Grubb BR, Rogers TD, et al. Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration[J]. Sci Transl Med, 2023, 15(699): eabo7728.
|
| 30 |
Kocot N, Pękala E, Koczurkiewicz-Adamczyk P, et al. Airway and cardiovascular remodeling in chronic obstructive pulmonary disease (COPD) as a target for transient receptor potential ankyrin 1 (TRPA1) channel modulators[J]. Bioorg Chem, 2025, 158: 108301.
|
| 31 |
俞力月，张明，吴楠，等. 慢性阻塞性肺疾病发病机制研究新进展[J]. 中国医学创新，2026, 23(1): 181-185.
|
| 32 |
Baltazar-García EA, Vargas-Guerrero B, Gasca-Lozano LE, et al. Molecular changes underlying pulmonary emphysema and chronic bronchitis in chronic obstructive pulmonary disease: An updated review[J]. Histol Histopathol, 2024, 39(7): 805-816.
|
| 33 |
Liang Z, Long F, Deng K, et al. Dissociation between airway and systemic autoantibody responses in chronic obstructive pulmonary disease[J]. Ann Transl Med, 2020, 8(15): 918.
|
| 34 |
任杰，祖力皮喀尔·阿卜杜热合曼，弓慧，等. COPD中MicRNA-320c-5p调节SERPINA1基因表达的研究[J]. 河北医科大学学报，2023, 44(2): 137-141.
|
| 35 |
Huo X, Jin S, Wang Y, et al. DNA methylation in chronic obstructive pulmonary disease[J]. Epigenomics, 2021, 13(14): 1145-1155.
|
| 36 |
Chen Z, Yang Y, Peng C, et al. Mendelian randomisation studies for causal inference in chronic obstructive pulmonary disease: A narrative review[J]. Pulmonology, 2025, 31(1): 2470556.
|
| 37 |
Li N, Dai Z, Wang Z, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease[J]. Respir Res, 2021, 22(1): 274.
|
| 38 |
D′Anna SE, Maniscalco M, Cappello F, et al. Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease[J]. Ann Med, 2021, 53(1): 135-150.
|
| 39 |
Meldrum OW, Donaldson GC, Narayana JK, et al. Accelerated lung function decline and mucus-microbe evolution in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2024, 210(3): 298-310.
|
| 40 |
Subedi S, Guntipally M, Suwal N, et al. Cellular senescence in chronic obstructive pulmonary disease: Molecular mechanisms and therapeutic interventions[J]. Ageing Res Rev, 2025, 110: 102813.
|
| 41 |
Easter M, Bollenbecker S, Barnes JW, et al. Targeting aging pathways in chronic obstructive pulmonary disease[J]. Int J Mol Sci, 2020, 21(18): 6924.
|
| 42 |
Bontsevich RA, Adonina AV, Vovk YR, et al. Management of chronic obstructive pulmonary disease[J]. Arch Razi Inst, 2022, 77(1): 439-447.
|
| 43 |
MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact[J]. Respirology, 2021, 26(6): 532-551.
|
| 44 |
Baou K, Katsi V, Makris T, et al. Beta Blockers and chronic obstructive pulmonary disease (COPD): Sum of evidence[J]. Curr Hypertens Rev, 2021, 17(3): 196-206.
|
| 45 |
Tanimura K, Sato S, Fujita Y, et al. The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis[J]. Chron Respir Dis, 2023, 20: 14799731231166008.
|
| 46 |
Lea S, Higham A, Beech A, et al. How inhaled corticosteroids target inflammation in COPD[J]. Eur Respir Rev, 2023, 32(170): 230084.
|
| 47 |
王声祥，代文娟，颜晶晶，等. 三联吸入型药物治疗稳定期慢性阻塞性肺疾病有效性和安全性的网状Meta分析[J]. 实用心脑肺血管病杂志，2025, 33(5): 7-15.
|
| 48 |
王婷，刘晓艳，王红伍，等. 布地奈德/格隆溴铵/福莫特罗三联制剂治疗中重度老年慢性阻塞性肺疾病患者的临床研究[J]. 中国临床药理学杂志，2023, 39(22): 3195-3198.
|
| 49 |
马群，李卫阳，许蒙，等. N-乙酰半胱氨酸治疗AECOPD合并呼吸衰竭患者的临床研究[J]. 中国临床药理学杂志，2025, 41(5): 606-610.
|
| 50 |
秦旭，佟振博，任红贤. 经口吸入装置的发展趋势及智能化[J]. 中国医药工业杂志，2023, 54(7): 984-992.
|